484 related articles for article (PubMed ID: 16257125)
1. Preventing radiation induced xerostomia.
Koukourakis MI; Danielidis V
Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
[TBL] [Abstract][Full Text] [Related]
2. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
de Castro G; Federico MH
Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
[TBL] [Abstract][Full Text] [Related]
3. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
4. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
5. Pilocarpine in the prevention of postirradiation xerostomia.
Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
[TBL] [Abstract][Full Text] [Related]
6. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
[TBL] [Abstract][Full Text] [Related]
7. New approaches to preventing xerostomia.
J Support Oncol; 2006 Feb; 4(2):87-8. PubMed ID: 16499130
[No Abstract] [Full Text] [Related]
8. [Effect of Cepharanthin to prevent radiation induced xerostomia in head and neck cancer].
Imada H; Nomoto S; Ohguri T; Yahara K; Kato F; Morioka T; Korogi Y
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1041-5. PubMed ID: 15272582
[TBL] [Abstract][Full Text] [Related]
9. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
Sangthawan D; Watthanaarpornchai S; Phungrassami T
J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
[TBL] [Abstract][Full Text] [Related]
10. The role of saliva in oral health: strategies for prevention and management of xerostomia.
Brosky ME
J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
[TBL] [Abstract][Full Text] [Related]
11. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
Chambers MS; Garden AS; Kies MS; Martin JW
Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
[TBL] [Abstract][Full Text] [Related]
13. The prevention and treatment of radiotherapy - induced xerostomia.
Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Thorstad WL; Chao KS; Haughey B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
17. Drug used during radiotherapy helps reduce dry mouth problem.
Expert Rev Anticancer Ther; 2001 Jun; 1(1):4. PubMed ID: 12113130
[No Abstract] [Full Text] [Related]
18. Radiation-induced xerostomia: how dry is your patient?
Bruce SD
Clin J Oncol Nurs; 2004 Feb; 8(1):61-7. PubMed ID: 14983765
[TBL] [Abstract][Full Text] [Related]
19. [Xerostomia caused by radiotherapy of patients with head and neck cancer].
Bentzen JK
Ugeskr Laeger; 1992 Jan; 154(3):126-9. PubMed ID: 1738952
[TBL] [Abstract][Full Text] [Related]
20. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
Nakamura N; Sasano N; Yamashita H; Igaki H; Shiraishi K; Terahara A; Asakage T; Nakao K; Ebihara Y; Ohtomo K; Nakagawa K
Auris Nasus Larynx; 2009 Jun; 36(3):310-3. PubMed ID: 18635328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
